BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 37004782)

  • 1. ROS-responsive self-activatable photosensitizing agent for photodynamic-immunotherapy of cancer.
    Wang N; Zhao Z; Xiao X; Mo L; Yao W; Yang H; Wang J; Wei X; Yuan Y; Yang R; Jiang X
    Acta Biomater; 2023 Jul; 164():511-521. PubMed ID: 37004782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
    Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
    Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactivatable reactive oxygen species-sensitive nanoparticulate system for chemo-photodynamic therapy.
    Kim Y; Uthaman S; Pillarisetti S; Noh K; Huh KM; Park IK
    Acta Biomater; 2020 May; 108():273-284. PubMed ID: 32205212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy.
    Huang Z; Chen Y; Zhang J; Li W; Shi M; Qiao M; Zhao X; Hu H; Chen D
    ACS Appl Mater Interfaces; 2021 Aug; 13(33):39934-39948. PubMed ID: 34396771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-amplified activatable nanophotosensitizers for HIF-1α inhibition-enhanced photodynamic therapy.
    Guo Z; Wang N; He X; Shen J; Yang X; Xie C; Fan Q; Zhou W
    Nanoscale; 2024 Feb; 16(8):4239-4248. PubMed ID: 38348473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photosensitizer-driven nanoassemblies of homodimeric prodrug for self-enhancing activation and synergistic chemo-photodynamic therapy.
    Zhang S; Wang Z; Kong Z; Wang Y; Zhang X; Sun B; Zhang H; Kan Q; He Z; Luo C; Sun J
    Theranostics; 2021; 11(12):6019-6032. PubMed ID: 33897896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria-targeting and ROS-sensitive smart nanoscale supramolecular organic framework for combinational amplified photodynamic therapy and chemotherapy.
    Tian J; Huang B; Cui Z; Wang P; Chen S; Yang G; Zhang W
    Acta Biomater; 2021 Aug; 130():447-459. PubMed ID: 34082096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-facilitated ROS-responsive nanoassembly of heterotypic dimer for synergistic chemo-photodynamic therapy.
    Luo C; Sun B; Wang C; Zhang X; Chen Y; Chen Q; Yu H; Zhao H; Sun M; Li Z; Zhang H; Kan Q; Wang Y; He Z; Sun J
    J Control Release; 2019 May; 302():79-89. PubMed ID: 30946853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cascade-amplifying synergistic effects of chemo-photodynamic therapy using ROS-responsive polymeric nanocarriers.
    Sun CY; Cao Z; Zhang XJ; Sun R; Yu CS; Yang X
    Theranostics; 2018; 8(11):2939-2953. PubMed ID: 29896295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light-responsive smart nanocarriers for wirelessly controlled photodynamic therapy for prostate cancers.
    Sun B; Liu J; Kim HJ; Rahmat JNB; Neoh KG; Zhang Y
    Acta Biomater; 2023 Nov; 171():553-564. PubMed ID: 37739246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-amplified chain-shattering cinnamaldehyde-based poly(thioacetal) boosts cancer chemo-immunotherapy.
    Zong Q; Li J; Xiao X; Du X; Yuan Y
    Acta Biomater; 2022 Dec; 154():97-107. PubMed ID: 36210042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Light triggered release of a triple action porphyrin-cisplatin conjugate evokes stronger immunogenic cell death for chemotherapy, photodynamic therapy and cancer immunotherapy.
    Song H; Cai Z; Li J; Xiao H; Qi R; Zheng M
    J Nanobiotechnology; 2022 Jul; 20(1):329. PubMed ID: 35842642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable NIR-II Pseudo Conjugate Polymeric Nanoparticles Amplify Photodynamic Immunotherapy via Alleviation of Tumor Hypoxia and Tumor-Associated Macrophage Reprogramming.
    Wan J; Zhang X; Tang D; Liu T; Xiao H
    Adv Mater; 2023 Aug; 35(31):e2209799. PubMed ID: 37276889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
    Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
    J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable Materials with Disulfide-Bridged-Framework Confine Photosensitizers for Enhanced Photo-Immunotherapy.
    Li D; Chen F; Cheng C; Li H; Wei X
    Int J Nanomedicine; 2021; 16():8323-8334. PubMed ID: 34992368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy.
    Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J
    Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional Novel Nanoplatform for Effective Synergistic Chemo-Photodynamic Therapy of Breast Cancer by Enhancing DNA Damage and Disruptions of Its Reparation.
    Huang Z; Xian T; Meng X; Hu H; Gao L; Huang J; Yang D; Ou K; Wang B; Zhang Y
    Molecules; 2023 Oct; 28(19):. PubMed ID: 37836815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIE-Active Photosensitizers: Manipulation of Reactive Oxygen Species Generation and Applications in Photodynamic Therapy.
    Yu H; Chen B; Huang H; He Z; Sun J; Wang G; Gu X; Tang BZ
    Biosensors (Basel); 2022 May; 12(5):. PubMed ID: 35624649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoplasmic Reticulum-Targeting AIE Photosensitizers to Boost Immunogenic Cell Death for Immunotherapy of Bladder Carcinoma.
    Miao Z; Li J; Zeng S; Lv Y; Jia S; Ding D; Li W; Liu Q
    ACS Appl Mater Interfaces; 2024 Jan; 16(1):245-260. PubMed ID: 38113527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy-improved oncolytic bacterial immunotherapy with FAP-encoding S. typhimurium.
    Guo Y; Song M; Liu X; Chen Y; Xun Z; Sun Y; Tan W; He J; Zheng JH
    J Control Release; 2022 Nov; 351():860-871. PubMed ID: 36181917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.